Posted by Michael Wonder on 31 Jul 2019
Two powerful Canadian provinces argued against federal drug price crackdown
31 July 2019 - Canada’s two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan to slash the price of patented drugs, arguing that such regulatory changes could hurt investment in life sciences.
The Canadian government has said it plans to soon publish a final version of new regulations aimed at cutting patented drug prices that are among the highest in the world. Announced in 2017, the changes were expected to take effect in January, but the government delayed them to review feedback.
With an election set for October, time is running out.
